DCPS
Basic information
Region (hg38): 11:126304060-126350005
Links
Phenotypes
GenCC
Source:
- Al-Raqad syndrome (Moderate), mode of inheritance: AR
- Al-Raqad syndrome (Strong), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Al-Raqad syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 25701870; 25712129 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCPS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 17 | ||||
missense | 34 | 40 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 1 | |||||
Total | 0 | 4 | 35 | 20 | 4 |
Variants in DCPS
This is a list of pathogenic ClinVar variants found in the DCPS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-126304087-G-A | Inborn genetic diseases | Uncertain significance (Mar 19, 2024) | ||
11-126304096-C-T | Uncertain significance (Jan 22, 2024) | |||
11-126304097-C-T | Inborn genetic diseases | Uncertain significance (Mar 24, 2023) | ||
11-126304105-G-C | Inborn genetic diseases | Uncertain significance (Aug 09, 2021) | ||
11-126304117-C-A | Inborn genetic diseases | Uncertain significance (Jan 02, 2024) | ||
11-126304121-A-G | Inborn genetic diseases | Uncertain significance (Dec 16, 2022) | ||
11-126304127-A-C | Inborn genetic diseases | Uncertain significance (May 29, 2024) | ||
11-126304143-C-T | Benign (Nov 16, 2020) | |||
11-126304150-A-C | Inborn genetic diseases | Uncertain significance (Jun 16, 2024) | ||
11-126304151-G-A | Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
11-126304167-G-T | Inborn genetic diseases • not specified | Conflicting classifications of pathogenicity (Jun 28, 2024) | ||
11-126304214-C-G | Uncertain significance (May 18, 2023) | |||
11-126304216-G-A | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
11-126304241-G-T | Inborn genetic diseases | Uncertain significance (Jan 31, 2023) | ||
11-126304269-C-T | Al-Raqad syndrome | Benign (Jul 30, 2021) | ||
11-126304282-G-T | Al-Raqad syndrome | Likely pathogenic (Sep 27, 2023) | ||
11-126304283-T-C | Al-Raqad syndrome | Pathogenic (Jul 29, 2019) | ||
11-126304285-C-G | Al-Raqad syndrome | Uncertain significance (Jan 17, 2019) | ||
11-126306583-C-CTGGGGA | Al-Raqad syndrome | Benign (May 04, 2023) | ||
11-126306595-A-T | Inborn genetic diseases | Uncertain significance (Aug 22, 2023) | ||
11-126306608-C-T | Likely benign (Sep 01, 2023) | |||
11-126306621-G-A | Inborn genetic diseases | Uncertain significance (May 15, 2024) | ||
11-126306628-C-T | Al-Raqad syndrome | Pathogenic (Jul 29, 2019) | ||
11-126306641-G-A | Likely benign (Nov 15, 2017) | |||
11-126306651-G-C | Inborn genetic diseases | Uncertain significance (Mar 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DCPS | protein_coding | protein_coding | ENST00000263579 | 6 | 41998 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.47e-7 | 0.497 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.495 | 228 | 208 | 1.10 | 0.0000126 | 2188 |
Missense in Polyphen | 55 | 54.582 | 1.0077 | 554 | ||
Synonymous | -0.997 | 104 | 91.8 | 1.13 | 0.00000576 | 684 |
Loss of Function | 0.855 | 12 | 15.7 | 0.767 | 8.35e-7 | 170 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000362 | 0.000362 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000972 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Decapping scavenger enzyme that catalyzes the cleavage of a residual cap structure following the degradation of mRNAs by the 3'->5' exosome-mediated mRNA decay pathway. Hydrolyzes cap analog structures like 7-methylguanosine nucleoside triphosphate (m7GpppG) with up to 10 nucleotide substrates (small capped oligoribonucleotides) and specifically releases 5'-phosphorylated RNA fragments and 7-methylguanosine monophosphate (m7GMP). Cleaves cap analog structures like tri-methyl guanosine nucleoside triphosphate (m3(2,2,7)GpppG) with very poor efficiency. Does not hydrolyze unmethylated cap analog (GpppG) and shows no decapping activity on intact m7GpppG-capped mRNA molecules longer than 25 nucleotides. Does not hydrolyze 7-methylguanosine diphosphate (m7GDP) to m7GMP (PubMed:22985415). May also play a role in the 5'->3 mRNA decay pathway; m7GDP, the downstream product released by the 5'->3' mRNA mediated decapping activity, may be also converted by DCPS to m7GMP (PubMed:14523240). Binds to m7GpppG and strongly to m7GDP. Plays a role in first intron splicing of pre- mRNAs. Inhibits activation-induced cell death. {ECO:0000269|PubMed:11747811, ECO:0000269|PubMed:12198172, ECO:0000269|PubMed:12871939, ECO:0000269|PubMed:14523240, ECO:0000269|PubMed:15273322, ECO:0000269|PubMed:15383679, ECO:0000269|PubMed:15769464, ECO:0000269|PubMed:16140270, ECO:0000269|PubMed:18426921, ECO:0000269|PubMed:22985415}.;
- Disease
- DISEASE: Al-Raqad syndrome (ARS) [MIM:616459]: A syndrome characterized by delayed psychomotor development, moderate to severe intellectual disability, poor or absent speech, microcephaly, congenital hypotonia, and severe growth delay. {ECO:0000269|PubMed:25701870, ECO:0000269|PubMed:25712129}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- RNA degradation - Homo sapiens (human);Metabolism of RNA;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.192
Intolerance Scores
- loftool
- 0.322
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.56
Haploinsufficiency Scores
- pHI
- 0.241
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.593
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.521
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dcps
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;deadenylation-dependent decapping of nuclear-transcribed mRNA;cellular response to menadione;negative regulation of programmed cell death;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;mRNA cis splicing, via spliceosome;RNA phosphodiester bond hydrolysis, exonucleolytic
- Cellular component
- P-body;nucleus;nucleoplasm;cytoplasm;mitochondrion;cytosol
- Molecular function
- RNA 7-methylguanosine cap binding;exoribonuclease activity;protein binding;m7G(5')pppN diphosphatase activity